VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

Go back to VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
(NASDAQ: VRXA) Delayed: 1.80 -0.06 (3.23%)
Previous Close $1.86    52 Week High
Open $1.89    52 Week Low
Day High $1.95    P/E N/A 
Day Low $1.78    EPS
Volume 175,300